
RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition
Shares of RAPT Therapeutics surged sharply on Tuesday after the biopharmaceutical company said it had agreed to be acquired by British drugmaker GS...

GSK names Luke Miels as next CEO after Emma Walmsley steps down; shares jump
GSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current Chief Commercial Officer Luke ...